Find Academic Supervisors

• Bioprinting
• Tissue Engineering
• Hydrogel Engineering
• +5 more

Vasileios Trikalitis is a Researcher at the University of Twente's Advanced Manufacturing, Sustainable Products & Energy Systems department, specializing in cutting-edge bioprinting methodologies for tissue engineering and vascularization. His work bridges advanced manufacturing with regenerative medicine through innovative hydrogel and bioink development. Education: PhD in Tissue Bioprinting (University of Twente, 2024) MSc (institution unspecified) His research focuses on solving fundamental challenges in vascular network formation within engineered tissues, with particular expertise in embedded 3D printing techniques using granular baths and shear-thinning materials. He pioneers approaches like aptamer-based programmable bioinks and Magnetic Nozzle-Free Embedded 3D Printing to achieve precise microvascular morphogenesis. His work integrates principles from hydrogel engineering, growth factor delivery, and microfluidics to create biomimetic tissue constructs. Analysis of his 2023-2025 publications reveals a strategic progression from foundational embedded printing techniques toward increasingly sophisticated vascularization strategies. Key trends include the development of multi-material printing systems, dynamic bioink programming for 4D tissue evolution, and integration of biological cues like vascular endothelial growth factors. His research consistently targets clinical translation barriers in regenerative medicine through engineering-first solutions. Scientific Awards: No awards documented in provided materials While no formal advising relationships or grant awards are specified, his extensive collaborative network—evident in co-authorships with Rouwkema, Misra, and Schwach—demonstrates active participation in large-scale research initiatives. His conference presentations track methodological evolution from basic bioprinting (2018-2019) toward advanced vascularization techniques (2023-2025). Dr. Trikalitis operates within University of Twente's interdisciplinary biomanufacturing ecosystem, contributing to teams focused on sustainable advanced manufacturing applications in medical technology. His work particularly advances the intersection of granular mechanics, hydrogel science, and vascular tissue engineering through experimental innovation.

Zsolt BagiView profile

Professor

• Cardiovascular Physiology
• Pharmacology
• Diabetes Mellitus
• +5 more

Zsolt Bagi, PhD, MD is a Professor at the Medical College of Georgia, Augusta University , with dual appointments in the Department of Physiology and the Department of Medicine: Cardiology . He received his MD and PhD from Semmelweis University Medical School in Hungary (2000, 2004) and held academic positions at New York Medical College (2002-2010), University of Oxford (2010-2012), and Augusta University (2013-present). His research focuses on coronary microvascular disease in diabetes mellitus and diastolic heart failure , with additional interests in Alzheimer's-related vascular injury and aging. Research Themes : Microvascular regulation in metabolic disorders Mechanisms of diastolic dysfunction Vascular contributions to neurodegenerative diseases Adenosine kinase and phosphodiesterase pathways Age-related arterial remodeling Obesity and vascular inflammation Recent Trends : His 2022-2024 publications emphasize phosphodiesterase 9A inhibition for pulmonary/coronary dysfunction, copper transport in Alzheimer's , sex-specific cardiac fibrosis , and microvascular-leptin interactions . Collaborative work explores neuro-glial-vascular dynamics in cognitive impairment and ADAM17's role in vascular aging. Scientific Recognition : Distinguished Research Award, Augusta University (2023) Fellow, APS Cardiovascular Section (2022) Bristol-Myers Squibb Young Investigator Award (2008) Van Leeuwenhoek Travel Award (2004) Zweifach Student Award (2004) Academic Service : Serves on editorial boards for Microcirculation , Journal of Vascular Research , and Am J Physiology-Heart . Chair of admission committees at Medical College of Georgia (2015-present). Lab Personnel : Liwei Lang (Assistant Research Scientist) Marta Bagine Balogh (Research Associate) Vadym Buncha (Graduate Student) Katherine Fopiano (Graduate Student)

Masuko Ushio-FukaiView profile

Professor

• Vascular Biology
• Redox Signaling
• Angiogenesis
• +5 more

Masuko Ushio-Fukai is a Professor in the Department of Medicine at the Medical College of Georgia, Augusta University. She is a prominent researcher in the Vascular Biology Center (VBC), where she serves as Director of the Redox Signaling Program. Her academic appointments include roles in both the Department of Medicine (Cardiology division) and The Graduate School, reflecting her dual commitment to research and education. Dr. Ushio-Fukai's research focuses on vascular biology with particular emphasis on redox signaling mechanisms in cardiovascular and metabolic diseases. Her laboratory was among the first to demonstrate that reactive oxygen species (ROS) derived from NADPH oxidase function as signaling molecules to promote VEGF signaling, angiogenesis, and post-ischemic neovascularization in peripheral arterial disease. She has pioneered research on copper transport proteins in angiogenesis, identifying novel mechanisms by which copper transporters like CTR1 and ATP7A regulate VEGFR2 signaling and endothelial function. Her work bridges basic redox biochemistry with translational applications for treating ischemic cardiovascular diseases, diabetes complications, and atherosclerosis. Analysis of her recent publications reveals a strong focus on the intersection of redox signaling, endothelial metabolism, and vascular function. Her research has evolved to incorporate cutting-edge approaches including redox proteomics, CRISPR/Cas9-mediated genetic models, and advanced imaging techniques. A consistent theme across her work is the investigation of how specific ROS targets/sensors (particularly sulfenylated proteins) mediate vascular adaptation to ischemia while excess ROS contributes to disease pathogenesis. Editorial Review Board Member for Reactive Oxygen Species (2018-Present) Editorial Board Member for Antioxidants (2017-Present) Editorial Board Member for Atherosclerosis and Vascular Medicine (2016-Present) Editorial Board Member for Journal of Molecular and Cellular Cardiology (2016-Present) NIH Reviewer for early career investigators Dr. Ushio-Fukai actively mentors graduate students and postdoctoral fellows through the Vascular Biology Center's educational programs. She serves on multiple committees including the VBC Faculty Search Committee, VBC post-doc evaluation committee, and VBC PhD student Oral Exam committee. Her laboratory has secured significant research funding, including an $11.3 million NIH grant to identify causes of vascular disease. The Vascular Biology Center provides state-of-the-art core facilities that support her research on redox signaling mechanisms in vascular biology.

• Hyaluronan metabolism
• Glycocalyx biology
• Inflammation
• +4 more

Sophie Dogne is a Researcher at the Namur Research Institute for Life Sciences (URPHYM) , University of Namur, Belgium. Her work spans biomedical and pharmaceutical sciences with a focus on hyaluronan metabolism and glycocalyx biology. Academic Rank: Researcher Institution: University of Namur Research Institute: URPHYM Her research explores: Glycocalyx impairment in diseases like hypertension and sepsis Hyaluronan dynamics in renal and vascular contexts Adipose tissue roles in glucose homeostasis Clinical implications in brain death and postoperative complications Recent publications highlight: Mechanistic studies of hyaluronidase-1 in cellular trafficking Adipose hyaluronan's metabolic effects Glycocalyx alterations in critical care scenarios Current projects include: Pathogenesis of overweight-induced hypertension (2024-2025) Investigating hyaluronan in clinical settings like bypass surgery Labs & Collaborations: URPHYM Institute at University of Namur Collaborations in Belgium and international networks

• Vascular Surgery
• Geriatrics
• Cardiovascular Diseases
• +5 more

Sammy D Eghbalieh, MD is a Clinical Assistant Professor in the Department of Surgery at Charles R. Drew University of Medicine and Science. His academic and clinical work centers on vascular and cardiovascular surgery with strong ties to geriatric implications in surgical outcomes. His research interests focus on vascular diseases, aging-related surgical complications, neointimal hyperplasia, vein graft adaptation, and angioplasty techniques. These areas reflect a deep engagement with both surgical innovation and physiological responses to vascular interventions, particularly in older populations. The publication trends from 2010 to 2016 show sustained research in vascular surgery, with key contributions in revascularization techniques, biomaterials like bovine pericardial patches, and cellular mechanisms in graft failure. The work spans human and animal studies, often integrating geriatrics with surgical science. Although no formal scientific awards are listed, his research has been referenced in clinical guidelines and patents, indicating real-world impact and clinical relevance. Dr. Eghbalieh has collaborated with researchers such as A. Dardik, K. Ziegler, and A. Muto. His work has attracted readership on platforms like Mendeley and engagement on social media and Facebook, suggesting academic visibility. There is no mention of formal advising roles or grant funding in the available data.

• Vascular Physiology
• Pulmonary Hypertension
• Prostacyclin Signalling
• +5 more

Professor Lucie Clapp is Professor of Vascular Physiology at University College London (UCL), Institute of Cardiovascular Science, and currently serves as Head of Pre-clinical & Fundamental Science and Deputy Director of the Institute. She has been a faculty member since 1996, progressing from Senior Lecturer to Reader (2002) and full Professor (2005). From 2015 to 2021 she was an elected professorial member of UCL Council. Education: PhD, University of London (1985) BSc (Pharmacology, 2:1), University of Bristol (1981) Post-doctoral fellowship & Instructor in Physiology, University of Massachusetts Medical School, USA (1985-1988) Research Interests: Professor Clapp’s work converges on vascular physiology, pulmonary hypertension, prostacyclin signalling and ion-channel pharmacology . Her laboratory deciphers the biophysical properties of vascular potassium channels and their roles in septic shock, vascular remodelling and pulmonary arterial hypertension (PAH). She explores prostacyclin analogues at membrane and nuclear receptors, with emphasis on PPARγ-mediated pathways and novel receptor targets. Complementary studies focus on circulating biomarkers, mitochondrial dynamics and calcineurin regulation of K ATP channels in smooth muscle. Publication Trends: Across 178 outputs, recent work (2020-2025) centres on prostacyclin mimetics, GPCR pharmacology, microRNA regulation, epigenetic therapeutics and liquid-biopsy biomarkers for cancer and cardiovascular disease, reflecting a seamless integration of fundamental pharmacology with translational medicine. Scientific Awards & Fellowships: Howard Sprague Fellowship, American Heart Association (AHA) Career Development Award, Wellcome Trust Senior Fellowship, Medical Research Council (1996-2006) Fellow, American Heart Association (2001) Fellow, Pulmonary Vascular Research Institute (2010) Fellow, Royal Society of Biology (2011) AstraZeneca Prize for Women in Pharmacology, British Pharmacological Society (2017) Advancement of Learning and Teaching Award, UCL (2013) Teaching, Advising & Grants: Professor Clapp is a passionate educator and mentor. She founded and directs the iBSc in Cardiovascular Science for 3rd-year medical students, leads the Heart & Circulation module (PHOL0007) and lectures on multiple BSc, MSc and PhD programmes. Since 2009 she has co-organised and mentored on the British Heart Foundation 4-year PhD scheme. She has secured long-term funding from the MRC, Wellcome Trust, United Therapeutics and other biotech partners, and has served on editorial boards ( British Journal of Pharmacology , 2009-2015) and grant-review panels worldwide. Labs & Consortia: She heads a vibrant laboratory within the Centre for Cardiovascular Physiology & Pharmacology , Rayne Building, and spearheads the UCL-wide Pulmonary Arterial Hypertension Consortium , uniting clinicians and scientists across affiliated hospitals. This network feeds into the national BRIDGE cohort study and the international Pulmonary Vascular Research Institute (PVRI) , where she sits on the Preclinical & Molecular Science Task Force.

Olcay ÖzverenView profile

Professor

• Cardiology
• Interventional Cardiology
• Heart Failure
• +5 more

Prof. Olcay Özveren is a distinguished cardiologist and Professor at Yeditepe University Faculty of Medicine, where he serves as Head of the Cardiology Department. With over two decades of academic and clinical experience, he has established himself as a leading expert in cardiology, particularly in interventional cardiology, heart failure, and echocardiography. His academic journey began at Istanbul University's Cerrahpasa Medical Faculty, followed by specialization training at Istanbul Kartal Kosuyolu High Specialization Training and Research Hospital. Education: Bachelor's Degree (1994-2000): Istanbul University, Cerrahpasa Medical Faculty Medical Specialization (2000-2005): Istanbul Kartal Kosuyolu High Specialization Training and Research Hospital Prof. Özveren's research spans multiple areas of cardiology including interventional cardiology, heart failure, electrophysiology, and cardiovascular imaging. His work particularly focuses on biomarkers for cardiovascular risk assessment, cardiac complications in metabolic disorders, and innovative approaches to diagnosing and treating coronary artery disease. He has made significant contributions to understanding the relationship between obesity, metabolic syndrome, and cardiac function, as well as exploring novel biomarkers for predicting outcomes in various cardiac conditions. Analysis of Prof. Özveren's recent publications reveals a strong emphasis on clinical cardiology research with practical applications. His work spans from investigating novel biomarkers for predicting contrast-induced kidney injury to examining the effects of bariatric surgery on cardiac function in obese patients. There's a clear pattern of research that bridges cardiology with other specialties including nephrology, endocrinology, and pulmonology, reflecting a comprehensive approach to cardiovascular health. Scientific Awards: Aventis Abstract Award (Mansiyon Ödülü) at 8th World Congress of Echocardiography and Vascular Ultrasound Aventis Abstract Award (Birincilik Ödülü) at 8th World Congress of Echocardiography and Vascular Ultrasound Turkish Cardiology Association Top Level Publication Award Prof. Özveren has supervised numerous medical students and residents throughout his career, contributing significantly to cardiovascular education. His teaching portfolio includes specialized courses on valvular heart diseases, infective endocarditis, hypertension, and pericardial diseases. He has also been involved in multiple research projects examining various aspects of cardiovascular disease, with a particular focus on clinical outcomes and diagnostic approaches. As Head of the Cardiology Department at Yeditepe University, Prof. Özveren leads a multidisciplinary team focused on advancing cardiovascular care through clinical practice, research, and education. His department is actively engaged in both basic and clinical research, with ongoing studies examining novel diagnostic approaches and treatment strategies for various cardiac conditions.

Filiz BakarView profile

Professor

• Neonatology
• Pediatrics
• Child Health
• +6 more

Filiz Bakar is a Professor at Yeditepe University's Faculty of Health Sciences, Department of Child Health and Pediatrics, with extensive expertise in neonatology and pediatric care. Her academic career spans over two decades with significant contributions to understanding neonatal jaundice, premature infant care, and pediatric infectious diseases. She maintains an active research profile with numerous publications in both Turkish and international journals. Education: Medical Degree (1986-1992): Çukurova University, Faculty of Medicine Specialist in Child Health and Diseases (1993-1998): Çukurova University, Faculty of Medicine (Thesis: Immune system and cytokines in children with sickle cell anemia) Sub-specialist in Neonatology (2000-2003): Başkent University, Faculty of Medicine (Thesis: Effect of early enteral iron support on erythrocyte and iron parameters in very low birth weight newborns) Professor Bakar's research focuses on critical aspects of newborn care, particularly neonatal jaundice management, feeding practices for premature infants, and complications in cesarean-delivered newborns. Her work bridges clinical practice with scientific investigation, addressing practical challenges in everyday pediatric care while contributing to evidence-based medicine in neonatology. She has published extensively on bilirubin metabolism, respiratory issues in newborns, and infectious disease management in pediatric populations. Analysis of her publication trends reveals consistent expertise in neonatal care with particular emphasis on physiological parameters in newborns, complications in special delivery circumstances, and management of common neonatal conditions. Her research demonstrates methodological rigor across observational studies, case reports, and clinical investigations, contributing significantly to understanding regional health patterns and evidence-based interventions in Turkish pediatric practice. Professor Bakar has presented her research at numerous international conferences including the European Congress of Perinatal Medicine, International Congress of Pediatrics, and various neonatology symposia. Her collaborative work extends across multiple Turkish institutions and includes international partnerships, reflecting the broader impact of her research in the global pediatric community. Her clinical work at Yeditepe University Hospital builds upon previous experience at Adana State Hospital and Başkent University Hospitals in Adana and Ankara. This extensive clinical background informs her research approach, ensuring practical relevance to everyday pediatric challenges while maintaining scientific rigor in investigation design and analysis.

Ahmed IbrahimView profile

Assistant Professor

• Ocular Angiogenesis
• Retinopathy of Prematurity (ROP)
• Proliferative Diabetic Retinopathy (PDR)
• +4 more

Ahmed Ibrahim, Ph.D., is an Assistant Professor jointly appointed in the Departments of Ophthalmology, Visual and Anatomical Sciences, and Pharmacology at Wayne State University, where he also teaches graduate-level toxicology courses. Education Bachelor of Pharmacy (BSc. Pharm, Hons.), 2002 M.Sc. in Pharmaceutical Sciences, 2006 Ph.D. in Pharmaceutical Sciences, 2011 Research Focus Dr. Ibrahim’s laboratory investigates the molecular and cellular underpinnings of angiogenesis-driven ocular diseases . His work centers on pathological ocular angiogenesis , the root cause of blinding disorders such as retinopathy of prematurity (ROP) , proliferative diabetic retinopathy (PDR) , and exudative age-related macular degeneration (wet AMD) . A central theme is endothelial metabolic reprogramming , aiming to discover FDA-approved drugs that can be repurposed to modulate energy metabolism in angiogenic endothelial cells and overcome resistance to anti-VEGF therapy. Recent Publication Themes Across the last decade, Dr. Ibrahim’s publications reveal a consistent trajectory from mechanistic studies of lipoxygenase pathways and oxidative stress to translational models of diabetic retinopathy , traumatic optic neuropathy , and AMD . His work integrates in vitro retinal endothelial cell assays, in vivo mouse models of disease, and pharmacological interventions, underscoring a commitment to identifying non-VEGF therapeutic targets. Teaching & Courses BIO7011 – Principles of Toxicology (Fall 2023) PHC7410 – Principles of Toxicology (Fall 2023) Contact Email: gt3759@wayne.edu

Lawrence DiebelView profile

Clinical Professor

• Trauma Surgery
• Surgical Critical Care
• Endocrine Surgery
• +3 more

Lawrence Diebel, MD is a Clinical Professor in the Department of Surgery at Wayne State University School of Medicine , specializing in Trauma, Surgical Critical Care, and Endocrine Surgery. His research focuses on post-shock barrier dysfunction, glycocalyx degradation, and microfluidic modeling of trauma-induced pathologies. Education : MD from Wayne State University, BS from Aquinas College Training : University of Minnesota Hospitals, Wayne State University/Detroit Medical Center Dr. Diebel's clinical expertise includes trauma care, critical care surgery, and endocrine surgery. He has contributed to studies on hemorrhagic shock, blood storage effects, and infection detection technologies. His recent publications analyze microfluidic models of trauma, glycocalyx protection mechanisms, and C. difficile detection in pandemic settings, reflecting interdisciplinary work at the intersection of surgery and biomedical engineering.

Michele Catherine MadiganView profile

Associate Professor

• Eye diseases
• Age-related changes
• Cell biology
• +6 more

Associate Professor Michele Catherine Madigan , affiliated with the School of Optometry and Vision Science at the University of New South Wales , is a leading researcher in ocular pathogenesis spanning development to aging. Her work focuses on three core areas: Ocular tumor microenvironment, particularly uveal melanoma therapy development Age-related retinal and choroidal changes in AMD Meibomian gland biology in dry eye disease . Her research approach combines human donor tissue analysis with in vitro models to study disease mechanisms. Key methodologies include Transcriptomic profiling of ocular cells Environmental challenge models for ocular surface Melanocyte biology in tumor and aging contexts Specializing in ocular anatomy and immunology, she advances understanding of posterior eye inflammation and therapeutic interventions. Recent publications highlight her expertise in ocular aging markers, environmental pollutant impacts on eye health, and transcriptomic approaches to retinal degeneration. Her work reveals connections between Melanocortin system regulation Smoke exposure effects on ocular surface Metabolic pathways in photoreceptor protection These studies demonstrate her commitment to translational vision science. Scientific recognition includes: 2021 Scientia Education Academy Highly Commended for student engagement 2020 Dean’s Excellence Award for Diversity & Inclusion Multiple School-level Community Engagement Awards Her research is supported by ARC Discovery Grants and Ophthalmic Research Institute of Australia funding.

Lavannya Mundayatil PanditView profile

Associate Professor

• Pulmonary Hypertension
• Pulmonary and Critical Care Medicine
• Molecular Mechanisms of Pulmonary Vascular Diseases

Dr. Lavannya M. Pandit is an Associate Professor (tenure-track) at Baylor College of Medicine and full-time staff physician at the Michael E. DeBakey Veterans Affairs Medical Center . She serves as Director of the DeBakey Pulmonary Hypertension Program and is a core faculty member at the Center for Translational Research on Inflammatory Diseases (CTRID) . Education: BS in Biology and History from Yale University (1996) MD from University of Texas Southwestern Medical School (2000) Residency in Internal Medicine at University of Iowa Hospitals and Clinics (2003) Fellowship in Pulmonary and Critical Care at Baylor College of Medicine (2008) Her research focuses on the physiologic and molecular mechanisms of pulmonary vascular diseases , particularly pulmonary arterial hypertension (PAH) and COPD. Key areas include potassium channel dysfunction, rho-kinase signaling, vascular remodeling, and exosome-mediated pathogenesis. She has published extensively in journals like NEJM , Hypertension , and British Journal of Pharmacology . Current research projects include studies on COPD biomarkers , anatomic microniches in PAH , and smooth muscle cell biology in pulmonary vasculopathy. Her work is funded by multiple VA grants, including a CAREER DEVELOPMENT AWARD and two active investigator-initiated grants ( Neutrophilic exosomes in COPD and Translational research on vascular remodeling ). Scientific Awards: VA Career Development Award (2013-2018)

Ulf SchöttView profile

Associate Professor

• Anesthesiology
• Intensive Care
• Coagulation
• +5 more

Ulf Schött is an Associate Professor in Anesthesiology and Intensive Care at Lund University's Department of Anesthesia and Intensive Care, affiliated since 2007 after clinical roles at Örebro Regional Hospital and Halmstad County Hospital. Though retired from clinical work in 2024, he remains academically active in research, supervision, and publishing, with over 155 research outputs and 8 completed projects. His research spans coagulation science, anticoagulant safety, and critical care physiology. Early work pioneered Plasmadex® (3% dextran 60) as a blood substitute, while recent studies investigate vitamin K-dependent proteins in critical illness, direct oral anticoagulants (DOACs), and viscoelastic coagulation monitoring via ROTEM. His fingerprint highlights expertise in Platelet Research (44%), Blood (35%), Coagulation (32%), and Vitamin K (31%). Recent publications (2024-2025) reveal a clinical-experimental synergy, examining DOAC interactions with physiological stressors (hypothermia/acidosis), vitamin K supplementation in critically ill patients, and glycocalyx-vascular disease links. These works predominantly employ observational and experimental designs, advancing perioperative coagulation management. Scientific recognition includes: Bästa vetenskapliga artikel Vaskulär Medicin 2021 (2022) Maggie Stephens scholarships (2013, 2014) Multiple poster awards (2011, 2013) As an educator, he has main-supervised 4 PhD students (including Gustav Ekbäck, 2001) and co-supervised 8 others, while guiding 45 medical Master's theses. His research was funded through projects like ‘Clinical investigation of New Oral Anticoagulants’ (2018-present) and ‘Monitoring of vitamin K-dependent proteins’ (2018-2021), often in collaboration with national health agencies. His work aligns with UN Sustainable Development Goal 3 (Good Health and Well-being), focusing on improving surgical and critical care safety through evidence-based coagulation management.

Michelle H. TheusView profile

Professor

• Neurotrauma
• Neuroinflammation
• Eph Receptor Signaling
• +7 more

Michelle H. Theus is a Professor of Molecular and Cellular Neurobiology at the Department of Biomedical Sciences and Pathobiology , Virginia-Maryland College of Veterinary Medicine, Virginia Tech. She serves as Director of the Neurotrauma Research Program and co-director of the Translational Biology, Medicine, and Health Graduate Program. Education: PhD in Neuropathology and Laboratory Medicine (2006), Medical University of South Carolina; Board Certifications in Clinical Laboratory Science and Histocompatibility Research Focus : Her work investigates Eph receptor signaling in neurovascular and neuroimmune responses after brain injury. Key areas include cerebrovascular remodeling, neuroinflammation, neurogenesis, and therapeutic peptide development for post-traumatic epilepsy and stroke recovery. Publications (2022-2025) emphasize single-cell transcriptomics of immune responses STING signaling in microglia EphA4’s role in efferocytosis collateral vessel mechanisms in stroke Her lab employs murine models and advanced imaging to study neurovascular integrity and innate immunity modulation. Grant Funding includes multiple NIH R01 awards (2019-2026) targeting age-dependent immunity in TBI, inflammation suppression, and stroke-related arteriogenesis.

Wei LiView profile

Research Fellow

• Protein Engineering
• Structural Biology
• TGF-beta Signaling
• +7 more

Dr. Wei Li is a British Heart Foundation Senior Basic Science Research Fellow at the Victor Phillip Dahdaleh Heart & Lung Research Institute, affiliated with the Department of Medicine at the University of Cambridge. Her work bridges structural biology, protein engineering, and cardiovascular medicine through studies of TGF-beta and BMP signaling pathways. PhD in Biochemistry (University of East Anglia) Postdoctoral research at Cambridge Institute for Medical Research Co-founder of Morphogen-IX (acquired by Centessa Pharmaceuticals) Research focuses on protein-protein recognition mechanisms in extracellular TGF-beta/BMP signaling, particularly the BMP9(10):ALK1:BMPRII pathway in vascular endothelial cells. Key findings include discoveries about redox-dependent BMP9 regulation, prodomain function in BMP10, endoglin's dual role in signaling, and the first crystal structures of BMPRII complexes. Her work has direct implications for hereditary haemorrhagic telangiectasia (HHT) , pulmonary arterial hypertension (PAH) , and preeclampsia. Selected publications highlight multidisciplinary approaches combining structural biology, proteomics, RNAseq, and in vivo models. Notable outputs include patents for non-osteogenic BMP variants and translational insights into vascular protection. Awards include the 2023 BHF Research Fellow of the Year and 2023 Eureka International Certificate in Translational Medicine. 2023 : Recognized for BHF leadership role in project grant committee Developed novel therapeutic BMP variants with clinical potential